13G Filing: Amzak Capital Management, Llc and Zosano Pharma Corp (NASDAQ:ZSAN)

CUSIP No. 98979H103

SCHEDULE 13G

Item 4.

Ownership:

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1:

Each of MK and GK is a manager of Amzak and may be deemed to share voting and investment power with respect to the Common Stock held by Amzak.  Each Reporting Person disclaims beneficial ownership of any Common Stock owned by any other Reporting Person.

(a)

Amount beneficially owned:

See the response(s) to Item 9 on the attached cover page(s).

(b)

Percent of class:   

See the response(s) to Item 11 on the attached cover page(s).

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote:

See the response(s) to Item 5 on the attached cover page(s).

(ii)

Shared power to vote or to direct the vote:

See the response(s) to Item 6 on the attached cover page(s).

(iii)

Sole power to dispose or to direct the disposition of:

See the response(s) to Item 7 on the attached cover page(s).

(iv)

Shared power to dispose or to direct the disposition of:

See the response(s) to Item 8 on the attached cover page(s).

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

Item 9.

Notice of Dissolution of Group.

Not applicable.